Browsing Technical documents and research evidence on COVID-19 by Title
Now showing items 404-423 of 1749
-
Covid-19 update: ADHD, renal transplant patients, care for covid-19 patients post discharge
(2020-07-02)Kieran Walsh, clinical director at BMJ, asks editors from BMJ Learning and BMJ Best Practice to summarise the latest clinical guidance related to covid-19. Abigail Davis discusses the latest guidance on ADHD and renal ... -
COVID-19 versus non-COVID-19 pneumonia: A retrospective cohort study
(2020-05-06)Background and Objective: Since the outbreak of coronavirus disease 2019 (COVID-19) in December 2019 in Wuhan, Hubei Province, China, it has spread around the world and become a global public health emergency. It is important ... -
COVID-19 versus non-COVID-19 pneumonia: A retrospective cohort study in Chengdu, China
(2020-05-12)Background and Objective: Since the outbreak of coronavirus disease 2019 (COVID-19) in December 2019 in Wuhan, Hubei Province, China, it has spread around the world and become a global public health emergency. It is important ... -
COVID-19 virus may have neuroinvasive potential and cause neurological complications: a perspective review
(2020-05-16)Coronavirus disease 2019 (COVID-19) was reported at the end of 2019 in China for the first time and has rapidly spread throughout the world as a pandemic. Since COVID-19 causes mild to severe acute respiratory syndrome, ... -
COVID-19: A Brief Overview of the Discovery Clinical Trial
(2020-04-10)COVID-19 (coronavirus disease 2019) is a worldwide outbreak of pneumonia and acute respiratory distress syndrome. It is unambiguously linked to the human–human transmission of a novel coronavirus. Mutagenomic analyses ... -
COVID-19: a promising cure for the global panic
(2020-04-04)The novel Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2, which is the causative agent of a potentially fatal disease that is of great global public health concern. The outbreak of COVID-19 is wreaking havoc ... -
COVID-19: An Informative Guide. Advice for Journalists
(2020-06-26)This document offers tools to help journalists practice responsible coverage of the pandemic using evidence-based information. It also proposes ways to approach coverage and encourages journalists to provide advice and ... -
COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese-Western Medicine for the Management of 2019 Novel Coronavirus Disease
(2020-03-13)As of 22 February 2020, more than 77662 cases of confirmed COVID-19 have been documented globally with over 2360 deaths. Common presentations of confirmed cases include fever, fatigue, dry cough, upper airway congestion, ... -
COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism
(2020-04)The novel coronavirus pneumonia (COVID-19) is an infectious acute respiratory infection caused by the novel coronavirus. The virus is a positive-strand RNA virus with high homology to bat coronavirus. In this study, conserved ... -
COVID-19: Chloroquine and hydroxychloroquine research
(2020-04-02)In some countries in the Americas, chloroquine or hydroxychloroquine is readily available, in some cases as an over-the-counter medicine. National authorities should take measures to control the use of these medicines and ... -
COVID-19: Chloroquine and hydroxychloroquine research, 6 April 2020
(2020-04-06)In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing ... -
COVID-19: Guidelines for Communicating about Coronavirus Disease 2019. A Guide for Leaders
(2020-06-26)Introduction: The outbreak of coronavirus 2019 disease (COVID-19) in Hubei, China, and the introduction of the virus into the Region of the Americas highlight the urgent need for clear, concise and consistent communication. ... -
COVID-19: Operational guidance for maintaining essential health services during an outbreak. Interim guidance, 25 March 2020
(2020-03-25)Introduction and overview: Health systems are being confronted with rapidly increasing demand generated by the COVID-19 outbreak. When health systems are overwhelmed, both direct mortality from an outbreak and indirect ... -
COVID-19: press releases and what you need to know
(2020)Ministry of Public Health website that includes access to files organized in two categories: press releases and "what you need to know". -
COVID-19: Public Compliance with and Public Support for Stay-at-Home Mitigation Strategies
(2020-04-24)Objectives: Governments worldwide have recommended unprecedented measures to mitigate the coronavirus disease 2019 (COVID-19) pandemic. As pressure mounts to scale back these measures, understanding public compliance with ... -
Covid-19: remote consultations
(2020-03-25)This graphic, intended for use in a primary care setting, is based on data available in March 2020, much of which is from hospital settings in China. It will be revised as more relevant data emerges. -
COVID-19: Roche Antibody Test – 14th May
(2020-05-14)What do sensitivity and specificity tell us? Sensitivity tells us the proportion of people who test positive, out of the population who should have tested positive. In this case, a sensitivity of 100% tells us that everybody ... -
The COVID-NMA initiative: A living mapping and living systematic review of Covid-19 trials
(2020)COVID-NMA is an international research initiative supported by the WHO and Cochrane. We provide a living mapping of COVID-19 trials available through interactive data visualizations. We are also conducting living evidence ...